About the Journal

ICAIRI Journal of AI in Anticancer Research is a peer-reviewed, open-access journal publishing original research at the intersection of artificial intelligence and oncology, spanning computational methods, cancer genomics, imaging and pathology, drug discovery, and clinical decision support.

Launched in 2026 as the flagship publication of the International Cancer Artificial Intelligence Research Institute (ICAIRI) www.icairi.org, IJAIAR was founded to give AI-driven oncology research a dedicated, rigorously reviewed home — at a time when this work is often scattered across broader computer science and clinical venues.

We welcome submissions from researchers at any career stage, anywhere in the world. Fee waivers are available for authors facing financial hardship. Browse our current issue, or read the Author Guidelines to get started.